4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Aclaris Therapeutics, Inc. (ACRS) operates in the Biotechnology industry and is headquartered in Wayne, United States with about 69 employees. Its market capitalization is roughly $730 million. In the fiscal year ended 2025-12-31, ACRS reported $8M in revenue and ($65M) in net income.
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States.
Interactive charts & full statements → Open the ACRS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $8M | $19M | $31M | $30M | — |
| Gross Profit | $0M | $3M | $13M | $18M | — |
| Operating Income (EBIT) | ($74M) | ($52M) | ($116M) | ($85M) | — |
| Net Income | ($65M) | ($132M) | ($88M) | ($87M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $2M | $1M | $3M | $2M | $2M | — |
| Gross Profit | $0M | ($0M) | $1M | ($0M) | ($0M) | — |
| Operating Income (EBIT) | ($22M) | ($22M) | ($17M) | ($17M) | ($18M) | — |
| Net Income | ($20M) | ($20M) | ($15M) | ($15M) | ($15M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $160M | $220M | $197M | $255M | — |
| Total Liabilities | $57M | $65M | $40M | $57M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ACRS viewer.
About TickerBase · Data methodology & sources